Baotou Dongbao Bio-Tech Co.,Ltd (SHE:300239)
5.56
+0.02 (0.36%)
Apr 30, 2026, 3:14 PM CST
SHE:300239 Revenue
Baotou Dongbao Bio-Tech Co.,Ltd had revenue of 190.53M CNY in the quarter ending March 31, 2026, with 1.32% growth. This brings the company's revenue in the last twelve months to 747.80M, down -10.03% year-over-year. In the year 2025, Baotou Dongbao Bio-Tech Co.,Ltd had annual revenue of 745.31M, down -15.78%.
Revenue (ttm)
747.80M
Revenue Growth
-10.03%
P/S Ratio
4.33
Revenue / Employee
525.14K
Employees
1,424
Market Cap
3.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 745.31M | -139.62M | -15.78% |
| Dec 31, 2024 | 884.93M | -89.58M | -9.19% |
| Dec 31, 2023 | 974.51M | 31.12M | 3.30% |
| Jan 1, 2023 | 943.40M | 331.23M | 54.11% |
| Jan 1, 2022 | 612.17M | 163.34M | 36.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anhui Fengyuan Pharmaceutical | 3.86B |
| Guizhou Yibai Pharmaceutical | 1.72B |
| Shaanxi Panlong Pharmaceutical Group Limited By Share | 1.11B |
| Anhui Sunhere Pharmaceutical Excipients | 956.32M |
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 849.26M |
| Zhejiang Shengda Bio-Pharm | 830.53M |
| Jiangxi Synergy Pharmaceutical | 828.66M |
| Honz Pharmaceutical | 466.12M |